.After antibody-drug conjugate (ADC) specialist Seagen was actually sold to Pfizer in 2015 for a who...
.On the heels of a stage 3 succeed that fell short to make an impression on real estate investors, I...
.Don't quit Monte Rosa Therapies currently. The Boston-based biotech is having a ball after signing ...
.Accept to recently's Chutes & Ladders, our roundup of substantial leadership hirings, firings an...
.Commemorating his company's upsized initial public offering (IPO), Septerna CEO Jeffrey Finer sound...
.AbbVie has come back to the resource of its antipsychotic powerhouse Vraylar in search of an additi...
.GenSight Biologics is actually full weeks away from losing loan. Again. The biotech merely possesse...
.Monopar Therapies is recouping a medication coming from the scrap heap of AstraZeneca's uncommon he...
.Along with new data out on Arcus Biosciences' speculative HIF-2a prevention, one group of experts f...
.After creating a gene therapy collaboration with Dyno Therapies in 2020, Roche is actually back for...